Compare $2257.HK vs $SCTX | Chartloom

Compare

$2257.HK vs $SCTX

2257.HK

Error

SCTX

Scribe Therapeutics Inc

Compare $2257.HK vs $SCTX

2257.HK

Error

SCTXScribe Therapeutics Inc

2257.HK

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

SCTXScribe Therapeutics Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.61x

Rev growth (TTM)

—

YTD performance

-2.2%

52W performance

-2.2%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

2257.HK

SCTX

Not enough overlapping price history for this window.

Detailed metrics comparison

2257.HK

SCTX

Scribe Therapeutics Inc

Market Cap

2257.HK

SCTX$372M

Enterprise Value

2257.HK

SCTX$374M

Price

2257.HK

SCTX$21.17

P/E Ratio

2257.HK

SCTXN/A

P/S Ratio

2257.HK

SCTX0.00x

EV/Sales

2257.HK

SCTX0.00x

EV/EBITDA

2257.HK

SCTX0.00x

P/B Ratio

2257.HK

SCTXN/A

P/FCF Ratio

2257.HK

SCTXN/A

EV/FCF

2257.HK

SCTX0.00x

PEG Ratio

2257.HK

SCTXN/A

Forward P/E (NTM)

2257.HK

SCTXN/A

Forward P/S (NTM)

2257.HK

SCTX29.61x

Revenue (TTM)

2257.HK

SCTX$0

Revenue Growth (YoY)

2257.HK

SCTXN/A

Forward Rev Growth

2257.HK

SCTX-43.3%

Gross Margin (TTM)

2257.HK

SCTX0.0%

Operating Margin (TTM)

2257.HK

SCTX0.0%

EBITDA Margin (TTM)

2257.HK

SCTX0.0%

Net Margin (TTM)

2257.HK

SCTX0.0%

FCF Margin (TTM)

2257.HK

SCTXN/A

Net Income (TTM)

2257.HK

SCTXN/A

FCF (TTM)

2257.HK

SCTX$0

EPS (TTM)

2257.HK

SCTX$0.00

ROE (TTM)

2257.HK

SCTX0.0%

ROA (TTM)

2257.HK

SCTX0.0%

ROIC (TTM)

2257.HK

SCTX0.0%

Cash

2257.HK

SCTX$36M

Debt

2257.HK

SCTX$38M

Net Cash/Debt

2257.HK

SCTX$-2M

Current Ratio (TTM)

2257.HK

SCTX0.57x

Quick Ratio (TTM)

2257.HK

SCTX0.56x

Debt/Equity (TTM)

2257.HK

SCTX0.00x

Debt/Assets (TTM)

2257.HK

SCTX0.0%

Interest Coverage (TTM)

2257.HK

SCTXN/A

Net Debt/EBITDA (TTM)

2257.HK

SCTX0.00x

Beta

2257.HK

SCTX-2.64

52W Performance

2257.HK

SCTX-2.2%

YTD Performance

2257.HK

SCTX-2.2%

% from 52W High

2257.HK

SCTX-46.5%

% from 52W Low

2257.HK

SCTX56.8%

Asset Turnover (TTM)

2257.HK

SCTX0.00x

FCF Yield (TTM)

2257.HK

SCTX0.0%

Earnings Yield (TTM)

2257.HK

SCTX0.0%

Dividend Yield (TTM)

2257.HK

SCTXN/A

Rule of 40

2257.HK

SCTX0.0

EV/GP/RG

2257.HK

SCTXN/A

Ticker research

View 2257.HK research View SCTX research

Metric	2257.HK	SCTX Scribe Therapeutics Inc
Market & Valuation
Market Cap		$372M
Enterprise Value		$374M
Price		$21.17
P/E Ratio		N/A
P/S Ratio		0.00x
EV/Sales		0.00x
EV/EBITDA		0.00x
P/B Ratio		N/A
P/FCF Ratio		N/A
EV/FCF		0.00x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		29.61x
Revenue & Growth
Revenue (TTM)		$0
Revenue Growth (YoY)		N/A
Forward Rev Growth		-43.3%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		0.0%
Net Margin (TTM)		0.0%
FCF Margin (TTM)		N/A
Net Income (TTM)		N/A
FCF (TTM)		$0
EPS (TTM)		$0.00
ROE (TTM)		0.0%
ROA (TTM)		0.0%
ROIC (TTM)		0.0%
Financial Health
Cash		$36M
Debt		$38M
Net Cash/Debt		$-2M
Current Ratio (TTM)		0.57x
Quick Ratio (TTM)		0.56x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		-2.64
52W Performance		-2.2%
YTD Performance		-2.2%
% from 52W High		-46.5%
% from 52W Low		56.8%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		0.0%
Earnings Yield (TTM)		0.0%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		N/A
Ticker research	View 2257.HK research	View SCTX research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

2257.HK

SCTX

Scribe Therapeutics Inc

Market Cap

2257.HK

SCTX$372M

Enterprise Value

2257.HK

SCTX$374M

Price

2257.HK

SCTX$21.17

P/E Ratio

2257.HK

SCTXN/A

P/S Ratio

2257.HK

SCTX0.00x

EV/Sales

2257.HK

SCTX0.00x

EV/EBITDA

2257.HK

SCTX0.00x

P/B Ratio

2257.HK

SCTXN/A

P/FCF Ratio

2257.HK

SCTXN/A

EV/FCF

2257.HK

SCTX0.00x

PEG Ratio

2257.HK

SCTXN/A

Forward P/E (NTM)

2257.HK

SCTXN/A

Forward P/S (NTM)

2257.HK

SCTX29.61x

Revenue (TTM)

2257.HK

SCTX$0

Revenue Growth (YoY)

2257.HK

SCTXN/A

Forward Rev Growth

2257.HK

SCTX-43.3%

Gross Margin (TTM)

2257.HK

SCTX0.0%

Operating Margin (TTM)

2257.HK

SCTX0.0%

EBITDA Margin (TTM)

2257.HK

SCTX0.0%

Net Margin (TTM)

2257.HK

SCTX0.0%

FCF Margin (TTM)

2257.HK

SCTXN/A

Net Income (TTM)

2257.HK

SCTXN/A

FCF (TTM)

2257.HK

SCTX$0

EPS (TTM)

2257.HK

SCTX$0.00

ROE (TTM)

2257.HK

SCTX0.0%

ROA (TTM)

2257.HK

SCTX0.0%

ROIC (TTM)

2257.HK

SCTX0.0%

Cash

2257.HK

SCTX$36M

Debt

2257.HK

SCTX$38M

Net Cash/Debt

2257.HK

SCTX$-2M

Current Ratio (TTM)

2257.HK

SCTX0.57x

Quick Ratio (TTM)

2257.HK

SCTX0.56x

Debt/Equity (TTM)

2257.HK

SCTX0.00x

Debt/Assets (TTM)

2257.HK

SCTX0.0%

Interest Coverage (TTM)

2257.HK

SCTXN/A

Net Debt/EBITDA (TTM)

2257.HK

SCTX0.00x

Beta

2257.HK

SCTX-2.64

52W Performance

2257.HK

SCTX-2.2%

YTD Performance

2257.HK

SCTX-2.2%

% from 52W High

2257.HK

SCTX-46.5%

% from 52W Low

2257.HK

SCTX56.8%

Asset Turnover (TTM)

2257.HK

SCTX0.00x

FCF Yield (TTM)

2257.HK

SCTX0.0%

Earnings Yield (TTM)

2257.HK

SCTX0.0%

Dividend Yield (TTM)

2257.HK

SCTXN/A

Rule of 40

2257.HK

SCTX0.0

EV/GP/RG

2257.HK

SCTXN/A

Ticker research

View 2257.HK research View SCTX research

Metric	2257.HK	SCTX Scribe Therapeutics Inc
Market & Valuation
Market Cap		$372M
Enterprise Value		$374M
Price		$21.17
P/E Ratio		N/A
P/S Ratio		0.00x
EV/Sales		0.00x
EV/EBITDA		0.00x
P/B Ratio		N/A
P/FCF Ratio		N/A
EV/FCF		0.00x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		29.61x
Revenue & Growth
Revenue (TTM)		$0
Revenue Growth (YoY)		N/A
Forward Rev Growth		-43.3%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		0.0%
Net Margin (TTM)		0.0%
FCF Margin (TTM)		N/A
Net Income (TTM)		N/A
FCF (TTM)		$0
EPS (TTM)		$0.00
ROE (TTM)		0.0%
ROA (TTM)		0.0%
ROIC (TTM)		0.0%
Financial Health
Cash		$36M
Debt		$38M
Net Cash/Debt		$-2M
Current Ratio (TTM)		0.57x
Quick Ratio (TTM)		0.56x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		-2.64
52W Performance		-2.2%
YTD Performance		-2.2%
% from 52W High		-46.5%
% from 52W Low		56.8%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		0.0%
Earnings Yield (TTM)		0.0%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		N/A
Ticker research	View 2257.HK research	View SCTX research